Molecular Genomic Testing for Breast Cancer: Utility for Surgeons

Area of Science:

• Oncology
• Genomics
• Clinical Medicine

Background:

• Molecular genomic testing provides crucial prognostic and predictive information.
• This information aids in personalizing breast cancer treatment strategies.
• It helps mitigate risks associated with overtreatment or undertreatment.

Purpose of the Study:

• To review currently available clinical genomic tests for breast cancer management.
• To discuss ongoing research on validating and expanding genomic test utility.
• To emphasize the importance of surgeons incorporating genomic tools into practice.

Main Methods:

• Literature review of available genomic tests for breast cancer.
• Discussion of current research validating genomic test applications.
• Explanation of clinical integration strategies for surgeons.

Main Results:

• Genomic tests offer valuable prognostic and predictive data for breast cancer.
• Ongoing research aims to broaden the utility of these tests across diverse populations.
• Clinical integration of genomic testing is essential for treatment individualization.

Conclusions:

• Genomic testing empowers clinicians to tailor breast cancer treatment effectively.
• Incorporating genomic tools can reduce patient morbidity and enhance outcomes.
• Surgeons play a key role in leveraging genomic information for improved patient care.